Abstract
The double-stranded DNA genome of vaccinia virus (VACV), the prototype poxvirus, contains approximately 200 open reading frames (ORFs) that are transcribed at early, intermediate, and late stages of infection. Previous high-throughput deep RNA sequencing allowed us to map 118 VACV early genes that are expressed before viral DNA replication and 93 postreplicative genes. However, the intermediate- and late-stage postreplicative genes could not be differentiated. Here, we synchronized infections with a reversible inhibitor of DNA replication and used a VACV mutant that conditionally transcribes late genes to sequence the two classes of mRNAs. In addition, each postreplicative ORF was individually expressed under conditions that distinguished intermediate and late classes. We identified 38 VACV genes that belong to the late class and 53 that belong to the intermediate class, with some of the latter continuing to be expressed late. These data allowed us to prepare a genome-wide early, intermediate, and late transcription map. Inspection of sequences upstream of these ORFs revealed distinctive characteristics of intermediate and late promoters and suggested that some promoters have intermediate and late elements. The intermediate genes encoded many DNA binding/packaging and core-associated proteins in addition to late transcription factors; the late genes encoded many morphogenesis and mature virion membrane proteins, including those involved in entry, in addition to early transcription factors. The top-ranked antigens for CD4(+) T cells and B cells were mainly intermediate rather than late gene products. The differentiation of intermediate and late genes may enhance understanding of poxvirus replication and lead to improvements in expression vectors and recombinant vaccines.
MeSH Terms
DNA, Complementary/chemistry,genetics
DNA, Viral/chemistry,genetics
Gene Expression Profiling
Gene Expression Regulation, Viral
Genes, Viral
Humans
Molecular Sequence Data
Poxviridae/genetics,growth & development
Promoter Regions, Genetic
RNA, Viral/biosynthesis,genetics
Sequence Analysis, DNA
Transcription, Genetic
Vaccinia virus
Chemicals
DNA, Complementary
DNA, Viral
RNA, Viral
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Yang Zhilong
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-3210, USA.
Reynolds Sara E
Martens Craig A
Bruno Daniel P
Porcella Stephen F
Moss Bernard
References (25)
25 references, click to expand
-
Structure of vaccinia virus late promoters.
J Mol Biol. 1989 Dec 20;210(4):771-84
PMID: 2515287
-
Derepression of a novel class of vaccinia virus genes upon DNA replication.
EMBO J. 1988 Nov;7(11):3487-92
PMID: 2850166
-
Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing.
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11513-8
PMID: 20534518
-
Bidirectional transcriptional promoters in the vaccinia virus genome.
Virology. 2009 Mar 1;385(1):198-203
PMID: 19064274
-
Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes.
J Virol. 1993 Jun;67(6):3515-27
PMID: 8098779
-
Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
Eur J Immunol. 1986 Dec;16(12):1479-87
PMID: 3493144
-
DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles.
J Virol. 1998 Jul;72(7):5769-80
PMID: 9621036
-
Genome-wide analysis of the 5' and 3' ends of vaccinia virus early mRNAs delineates regulatory sequences of annotated and anomalous transcripts.
J Virol. 2011 Jun;85(12):5897-909
PMID: 21490097
-
Conserved TAAAT motif in vaccinia virus late promoters: overlapping TATA box and site of transcription initiation.
EMBO J. 1986 May;5(5):1071-6
PMID: 3013615
-
Vaccinia virus l1 protein is required for cell entry and membrane fusion.
J Virol. 2008 Sep;82(17):8687-94
PMID: 18596103
-
A complex of seven vaccinia virus proteins conserved in all chordopoxviruses is required for the association of membranes and viroplasm to form immature virions.
Virology. 2004 Dec 20;330(2):447-59
PMID: 15567438
-
MochiView: versatile software for genome browsing and DNA motif analysis.
BMC Biol. 2010 Apr 21;8:49
PMID: 20409324
-
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3183-8
PMID: 9096367
-
Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes.
Cell. 1990 Jun 1;61(5):801-9
PMID: 2344616
-
Preparation of cell cultures and vaccinia virus stocks.
Curr Protoc Mol Biol. 2001 May;Chapter 16:Unit16.16
PMID: 18265123
-
Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes.
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2140-5
PMID: 18245380
-
Structure of vaccinia virus early promoters.
J Mol Biol. 1989 Dec 20;210(4):749-69
PMID: 2515286
-
Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus.
J Virol. 1992 Nov;66(11):6470-9
PMID: 1404599
-
Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters.
J Virol. 1992 Aug;66(8):4710-9
PMID: 1629951
-
Fitting a mixture model by expectation maximization to discover motifs in biopolymers.
Proc Int Conf Intell Syst Mol Biol. 1994;2:28-36
PMID: 7584402
-
Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein.
J Virol. 2006 Jul;80(14):6784-93
PMID: 16809284
-
The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.
J Virol. 1998 Sep;72(9):7012-23
PMID: 9696793
-
Poxvirus multiprotein entry-fusion complex.
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18572-7
PMID: 16339313
-
Mutational analysis of a vaccinia virus intermediate promoter in vivo and in vitro.
J Virol. 1990 Dec;64(12):6063-9
PMID: 2243387
-
Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.
Future Microbiol. 2010 Feb;5(2):221-39
PMID: 20143946